Stefania Trazzi

2.0k total citations
42 papers, 1.5k citations indexed

About

Stefania Trazzi is a scholar working on Genetics, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stefania Trazzi has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 28 papers in Molecular Biology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stefania Trazzi's work include Genetics and Neurodevelopmental Disorders (27 papers), Ubiquitin and proteasome pathways (9 papers) and Down syndrome and intellectual disability research (7 papers). Stefania Trazzi is often cited by papers focused on Genetics and Neurodevelopmental Disorders (27 papers), Ubiquitin and proteasome pathways (9 papers) and Down syndrome and intellectual disability research (7 papers). Stefania Trazzi collaborates with scholars based in Italy, United States and France. Stefania Trazzi's co-authors include Elisabetta Ciani, Renata Bartesaghi, Claudia Fuchs, Sandra Guidi, Roberto Rimondini, Giuliano Della Valle, Giovanni Perini, Marianna De Franceschi, Laura Calzà and Laura Gennaccaro and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Stefania Trazzi

40 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Trazzi Italy 22 785 757 319 197 168 42 1.5k
María Martínez de Lagrán Spain 19 788 1.0× 528 0.7× 629 2.0× 340 1.7× 13 0.1× 37 1.8k
Claudia Fuchs Italy 18 532 0.7× 648 0.9× 81 0.3× 138 0.7× 17 0.1× 27 924
Richard J. Siarey United States 16 677 0.9× 584 0.8× 846 2.7× 353 1.8× 15 0.1× 28 1.6k
Nadia P. Belichenko United States 13 454 0.6× 419 0.6× 117 0.4× 362 1.8× 13 0.1× 14 1.1k
Cara J. Westmark United States 23 768 1.0× 610 0.8× 46 0.1× 266 1.4× 26 0.2× 60 1.5k
Nicholas G. Irving United States 11 574 0.7× 579 0.8× 692 2.2× 154 0.8× 14 0.1× 15 1.3k
Georgina M. Aldridge United States 11 604 0.8× 349 0.5× 21 0.1× 254 1.3× 53 0.3× 24 1.2k
Rocío Ruiz Spain 21 803 1.0× 176 0.2× 114 0.4× 466 2.4× 14 0.1× 51 1.5k
José V. Sánchez‐Mut Spain 17 1.1k 1.4× 459 0.6× 19 0.1× 157 0.8× 44 0.3× 25 1.6k
Hongen Wei China 17 376 0.5× 415 0.5× 30 0.1× 192 1.0× 15 0.1× 32 1.2k

Countries citing papers authored by Stefania Trazzi

Since Specialization
Citations

This map shows the geographic impact of Stefania Trazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Trazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Trazzi more than expected).

Fields of papers citing papers by Stefania Trazzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Trazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Trazzi. The network helps show where Stefania Trazzi may publish in the future.

Co-authorship network of co-authors of Stefania Trazzi

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Trazzi. A scholar is included among the top collaborators of Stefania Trazzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Trazzi. Stefania Trazzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Medici, Giorgio, Manuela Loi, Spase Stojanov, et al.. (2025). Lactic acid bacteria as microbial cell factories for the in vivo delivery of therapeutic proteins as secretable TAT fusion products. Journal of Biological Engineering. 19(1). 65–65. 1 indexed citations
2.
Medici, Giorgio, Manuela Loi, Greta Volpedo, et al.. (2025). Safety and efficacy of Igk-TATk-CDKL5 gene therapy in mosaic CDKL5 deficiency. Neurotherapeutics. 22(6). e00727–e00727.
3.
Tassinari, Elisa, Manuela Loi, Elisabetta Ciani, et al.. (2024). First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease. ACS Chemical Neuroscience. 15(11). 2099–2111. 3 indexed citations
4.
Lemaire, Valérie, Stefania Trazzi, Elisabetta Ciani, et al.. (2024). Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome. Neuropsychopharmacology. 49(13). 2032–2041. 2 indexed citations
5.
Loi, Manuela, et al.. (2023). Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder. Biomolecules. 13(9). 1396–1396. 3 indexed citations
6.
Loi, Manuela, Stefano Bastianini, Nicola Rizzardi, et al.. (2023). Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder. International Journal of Molecular Sciences. 24(6). 5552–5552. 4 indexed citations
7.
Galvani, Giuseppe, Laura Gennaccaro, Manuela Loi, et al.. (2022). Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder. International Journal of Molecular Sciences. 23(15). 8719–8719. 21 indexed citations
8.
Medici, Giorgio, Giuseppe Galvani, Stefano Bastianini, et al.. (2022). Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder. Neurotherapeutics. 19(6). 1886–1904. 9 indexed citations
9.
Loi, Manuela, Laura Gennaccaro, Claudia Fuchs, et al.. (2021). Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder. International Journal of Molecular Sciences. 22(11). 5950–5950. 13 indexed citations
10.
Galvani, Giuseppe, Laura Gennaccaro, Manuela Loi, et al.. (2021). Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder. Journal of Neuroinflammation. 18(1). 155–155. 31 indexed citations
11.
Gennaccaro, Laura, Claudia Fuchs, Manuela Loi, et al.. (2021). A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder. Neurobiology of Disease. 153. 105304–105304. 11 indexed citations
12.
Gennaccaro, Laura, Claudia Fuchs, Manuela Loi, et al.. (2021). Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and Death. Aging and Disease. 12(3). 764–764. 24 indexed citations
13.
Fuchs, Claudia, Laura Gennaccaro, Elisa Ren, et al.. (2019). Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder. Neuropharmacology. 167. 107746–107746. 13 indexed citations
14.
Fuchs, Claudia, Giorgio Medici, Stefania Trazzi, et al.. (2019). CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling. Brain Pathology. 29(5). 658–674. 20 indexed citations
15.
Fuchs, Claudia, et al.. (2018). Treatment with the GSK3‐beta inhibitor Tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice. European Journal of Neuroscience. 47(9). 1054–1066. 31 indexed citations
16.
Stagni, Fiorenza, Andrea Giacomini, Marco Emili, et al.. (2016). Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome. Neuroscience. 333. 277–301. 57 indexed citations
17.
Trazzi, Stefania, Claudia Fuchs, Marianna De Franceschi, et al.. (2016). HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder. Human Molecular Genetics. 25(18). 3887–3907. 78 indexed citations
18.
Fuchs, Claudia, Roberto Rimondini, Stefania Trazzi, et al.. (2015). Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder. Neurobiology of Disease. 82. 298–310. 55 indexed citations
19.
Bianchi, Patrizia, Simone Bettini, Sandra Guidi, et al.. (2013). Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome. Experimental Neurology. 251. 1–11. 20 indexed citations
20.
Fila, Tatiana, Stefania Trazzi, Christophe Crochemore, Renata Bartesaghi, & Elisabetta Ciani. (2009). Lot1 Is a Key Element of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/Cyclic AMP Pathway That Negatively Regulates Neuronal Precursor Proliferation. Journal of Biological Chemistry. 284(22). 15325–15338. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026